Inflammatory Bowel Disease: Mechanisms, Redox Considerations, and Therapeutic Targets

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Therapeutic Targets in Inflammatory Bowel Disease: Current and Future

IBD ETIOLOGY AND PATHOGENESIS Infl ammatory bowel disease (IBD) is a collection of disorders characterized by idiopathic infl ammation of the gastrointestinal tract. Although primarily classifi ed as either ulcerative colitis (UC) or Crohn’s disease (CD), the presentation of IBD can vary in terms of clinical symptoms, including location of disease involvement, disease severity, age at diagnosis...

متن کامل

Stem cells as potential therapeutic targets for inflammatory bowel disease.

The incidence and prevalence of Crohn's disease and ulcerative colitis, the two major forms of inflammatory bowel disease (IBD), are rising. According to some estimates >1 million new cases of IBD arise in the United States annually. The conventional therapies available for IBD range from anti-inflammatory drugs to immunosuppressive agents, but these therapies generally fail to achieve satisfac...

متن کامل

New therapeutic approach in inflammatory bowel disease.

In the last decade, biologic agents, in particular infliximab and adalimum-ab, have deeply changed the therapeutic armamentarium of inflammatory bowel disease (IBD). However, these drugs have a number of contraindications and side-effects that physicians should know so to avoid and eventually manage them. Another important issue is the early introduction of immunomodulators and biologics in the...

متن کامل

Therapeutic drug monitoring in inflammatory bowel disease

PURPOSE OF REVIEW There are an expanding number of therapies available to treat pediatric inflammatory bowel disease (IBD). As pediatric gastroenterologists attempt to achieve complete intestinal mucosal healing for their patients, it has become more important to gain an understanding of how to maximize the efficacy of our medications while minimizing their toxicities. We aim to provide an over...

متن کامل

Neonatal Presentation of Unremitting Inflammatory Bowel Disease

Very-early-onset inflammatory bowel disease (VEO-IBD) has a distinct phenotype and should be considered a specific entity. VEO-IBD presents with very severe clinical pictures and is frequently known by an indeterminate colitis whose clinical remission is unmanageable. This study examines the case of a neonate with VEO-IBD, not responding to medical and surgical treatment. A 7-day-old Iranian fe...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Antioxidants & Redox Signaling

سال: 2013

ISSN: 1523-0864,1557-7716

DOI: 10.1089/ars.2012.4530